Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_assertion description "[The combined treatment with anti-miR-155 and losartan has a synergistic antiproliferative effect and an improved understanding is required to clarify whether miR-155 and AGTR1 can be used as a novel therapeutic target in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_assertion evidence source_evidence_literature NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_assertion SIO_000772 22525818 NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_assertion wasDerivedFrom befree-20140225 NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_assertion wasGeneratedBy ECO_0000203 NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP286105.RAwDvEl_M-xO3OBDqFNtDa4TT2MLHmRQr-7I4dSkvAxfg130_provenance.